Evidence map›Paper›PMID 30521521›Full record

Trial reportPloS one2018

A pragmatic cluster randomised controlled trial of a tailored intervention to improve the initial management of suspected encephalitis.

Ruth Backman, Robbie Foy, Peter J Diggle, Rachel Kneen, Ava Easton, Sylviane Defres, Fiona McGill, Benedict Daniel Michael, Tom Solomon, ENCEPH UK Programme Steering Committee

Open access · goldAbstract readMulticenter StudyPragmatic Clinical TrialRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Observational
  5. Article
  6. Global Landscape of Encephalitis: Key Priorities to Reduce Future Disease Burden.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Review
  7. Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ruth BackmanDepartment of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.ORCID 0000-0001-6931-8672
Robbie FoyLeeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.
Peter J DiggleLancaster Medical School, Lancaster University, Lancaster, United Kingdom.
Rachel KneenDepartment of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Ava EastonDepartment of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Sylviane DefresDepartment of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Fiona McGillDepartment of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Benedict Daniel MichaelDepartment of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Tom SolomonDepartment of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
ENCEPH UK Programme Steering Committee
University of Liverpool · GBUniversity of Leeds · GB

Funding

Department of Health 12/205/28Department of Health DRF-2010-03-97Department of Health IS-HPU-1112-10117Department of Health RP-PG-0108-10048
6 · The paper itself

Abstract

objectiveTo determine whether a tailored multifaceted implementation strategy improves the initial management of patients with suspected encephalitis.

designPragmatic two arm cluster randomised controlled trial.

settingHospitals within the United Kingdom.

participantsTwenty-four hospitals nested within 12 postgraduate deaneries. Patients were identified retrospectively by searching discharge, microbiology, radiology and pharmacy records and included if they met clinical criteria or had a recorded suspicion of encephalitis.

interventionAn implementation strategy designed to overcome barriers to change, comprising local action planning, education and training, feedback on performance, a lumbar puncture pack and a range of optional components. OUTCOMES: The primary outcome was the proportion of patients with suspected encephalitis undergoing diagnostic lumbar puncture within 12 hours of admission and starting aciclovir treatment within six hours. Secondary outcomes included the proportions of adults and children who had a lumbar puncture, who had appropriate cerebrospinal fluid investigations, and who had appropriate radiological imaging within 24 hours of admission. Data were collected from patient records for 12 months before and 12 months during the intervention period, and analysed blind to allocation.

results13 hospitals were randomised to intervention and 11 to control (no intervention), with 266 and 223 patients with suspected encephalitis identified respectively. There was no significant difference in primary outcome between intervention and control hospitals (13.5% and 14.8% respectively, p = 0.619; treatment effect -0.188, 95% confidence interval -0.927 to 0.552), but both had improved compared to pre-intervention (8.5%).

conclusionThe improvement in both intervention and control arms may reflect overall progress in management of encephalitis through wider awareness and education.

trial registrationControlled Trials: ISRCTN06886935.

Indexed as

AcyclovirAdolescentAdultAgedAged, 80 and overChildChild, PreschoolEncephalitisFemaleHumansInfantInfant, NewbornMaleMiddle AgedSpinal PunctureUnited KingdomAcyclovir

Identifiers

PMID30521521
PMCPMC6283633
OpenAlexW2903762040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.